 |
 |
|
|
2nd Conference Innovation in From preformulation to development through
3-6 October 2010, Aix-en-Provence, France Aix Congress Center / Centre de congrès 14, boulevard Carnot 13100 Aix-en-Provence (France) |
tel : +33(0)146602510 / +33(0)629366739 - fax : 33146835308 - Contact: Catharina Kroling e-mail
After the first "Innovation in Drug Delivery" which took place in Naples (2007) with special emphasis on Biomaterials and Devices, APGI and ADRITELF are pleased to announce the second conference of the series.
This
time, we will follow the different steps of the drug delivery system
creation: from preformulation to formulation and industrial
development, and highlight the role of precise tools for the
characterization and evaluation at each level of the process. The
programme will include plenary and invited lectures as well as oral
contributions. The plenary lectures will also treat topics beyond drug
delivery. There will be technical sessions devoted to specific
scientific equipment or tools.
The conference will take place in Aix-en-Provence at the Congress Center*. You will discover the unique and charming alliance of history, with its palace, cathedral and mansion houses, literature with Zola and painting with Cezanne, and of modernity with its university as well as its international festival of lyric arts. You will enjoy walking in the small quiet streets of the centre and discover cafés, restaurants, fountains, flower markets and elegant shops. Aix is easily accessible by car, train or plane. We are sure that you will take this opportunity to discover the surrounding Provence.
Your presence as sponsor and/or as exhibitor
will demonstrate of your contribution and, of course, promote awareness
of your activities in the field, as this will clearly appear in the
conference documentation. There are various types of contribution you
may consider as shown in the attached documents: sponsorship,
exhibiting and advertising. Please feel free to contact us if you need
any further information
(Download sponsoring package).
We will be delighted to welcome you in Aix-en-Provence in 2010.
*Aix Congress Center / Centre de congrès
14, boulevard Carnot
13100 Aix-en-Provence (France)
Chairs and Organizing Committee
Co-Chairs
Prof. Elias Fattal, University of Paris-Sud, France
Prof. Ubaldo Conte, University of Pavia, Italy
Dr. Maria-Teresa Peracchia, Sanofi-Aventis, Paris, France
Prof. Andrea Gazzaniga, University of Milano, Italy
Organizing/Scientific Committee
Dr. Karine Andrieux, University of Paris-Sud, France
Prof. Ruggero Bettini, University of Parma, Italy
Prof. Anna Rita Bilia, University of Firenze, Italy
Dr. Kawthar Bouchemal, University of Paris-Sud, France
Prof. Odile Chambin, University of Dijon, France
Dr. Giuseppe De Rosa, University of Naples Federico II, Italy
Em. Prof. Dominique Duchêne, University of Paris-Sud, France
Dr. Anastasia Foppoli, University of Milano, Italy
Mrs Catharina Kroling, APGI, France
Dr. Pietro Matricardi, University of Roma, Italy
Prof. Franco Pattarino, University of Piemonte Orientale, Italy
Prof. Rosario Pignatello, University of Catania, Italy
Prof. Fabiana Quaglia, University of Naples Federico II, Italy
Prof. Juergen Siepmann, University of Lille, France
Plenary Lectures
Dr. Bernard Cabane, ENPC Paris, France
Micelles, Microemulsions and Emulsions as Drug Carriers: What are the Boundaries according to Thermodynamics?
Prof. Vladimir Torchilin, Northeastern University, Boston, MA, USA
Some Novel Approaches to the Delivery of DNA and siRNA
Prof. Carlo Ventura, Università di Bologna, Italy
Hyaluronan Mixed Esters of Butyric and Retinoic Acids: Differentiating and Paracrine Logics for Regenerative Medicine and Cardiovascular Repair
Invited Lectures
Prof. Anna Rita Bilia, University of Firenze, Italy
NMR Analysis of Aggregates and Supramolcular Complexes
Prof. Martyn Davies, University of Nottingham, United Kingdom
Nanotechnology in Drug Delivery
Dr. Jean Doucet, University of Paris-Sud, France
Novel Opportunities Offered by Synchrotron Light-based Techniques for the Design and Evaluation of Drug Delivery Systems
Prof. Massimo Fresta, University "Magna Græcia" Catanzaro, Italy
Targeted Colloidal Lipid-based Drug Carriers
Prof. Juan Manuel Irache, University of Navarra, Spain
Poly(anhydride) Nanoparticles for Oral Delivery of Poorly Available Drugs
Prof. Karsten Maeder, University of Halle, Germany
Noninvasive Monitoring of Drug Delivery by MRI, ESR and Optical Imaging
Dr. Sara Nicoli, University of Parma, Italy
Transscleral Delivery of Macromolecules: The Iontophoretic Approach
Prof. Gilles Ponchel, University of Paris-Sud, France
Characterization of Molecular Interactions as a Tool for Designing
Multifunctional Nanoparticles for Targeting Applications
Prof. Thomas Rades, University of Otago, New Zealand
Modern Spectroscopic Techniques to Characterize Pharmaceutical Solids
Dr. Céline Valéry, Ipsen, Barcelone, Spain
Peptide Self-assembly and Formulation: The Biomimetic Approach
Technical Sessions
Technical sessions devoted to
specific scientific equipment or tools. Sessions presented by sponsors
and exhibitors. If your company is interested to give a talk please
contact the organizers for further details. Only a limited number of
companies will be accepted.
Preliminary program of technical sessions
"A Systematic and Rational Approach to Lipid Based Formulation Development"
Dr Eduardo Jule, Capsugel, Belgium
"Organogels, a New Ttechnology for the Drug Sustained Delivery"
Dr Catherine Herry, Ethypharm SA, France
"In Vitro Evaluation of Supersaturating Drug Delivery Systems"
Dr Vincent Jannin, Gattefossé SA, France
"Excipient System for Making Durable Tablets at Low Pressure "
Dr Cecil Propst, Spi Pharma, USA
"Existing and New Drug Release Applications Related to the USP Apparatus 4"
Mr Samir Haddouchi, SOTAX-SPS Pharma Services, France
(to be confirmed)
Oral presentations
A large place will be given to oral presentations selected from the submitted abstracts.
Download the complete programme
Abstract must be clearly typed in English
The completed abstract form should be sent by e-mail or disk to the address:
APGI, 5 rue J.B. Clément, FR-92296 Châtenay-Malabry Cedex, France
e-mail : apgi.asso@u-psud.fr
Last days to submit an abstract (but only for poster presentation) !
If you need
a visa in order to enter into France, please return to APGI (apgi.asso@u-psud.fr) the "Letter of Invitation Form".
This form should be sent
as a Word document and NOT as a PDF document. We also kindly ask you to
send us a copy of your
passport.
If you intend to
send an abstract, and if you need a
letter of invitation, we must receive this form, with a copy of your
passport, before 1st May, 2010.
The temporary reference number will
be sent to you only after receipt of these documents.
We are pleased to invite you to present in the form of an oral lecture, constituting one of the three technical sessions of the conference. This possibility implies that to a normal sponsorship of your choice (bronze, silver, gold or platinum) or rental of an exhibition space, we will charge you with an additional sponsorship of 1500 €.
If this proposal, hold your attention, please note that the presentation should be of 15 minutes and 5 minutes for discussion. You can use visual support (PowerPoint presentation for example). Don't hesitate to contact us for any information or detail.
We look forward to your active participation to the 2nd Innovation in Drug Delivery Conference.
Contact: apgi.asso@u-psud.fr. Ref: Technical Session
See the programme above.
The Hotel Booking Service at the Tourist office in Aix-en-Provence has pre-booked hotel rooms in the town. This free service is made available to insure your hotel reservation.
As there is a high level of tourist activity in Aix-en-Provence, we strongly recommend that you send back the hotel registration as soon as possible.
To benefit from preferential tariffs, the hotel registration form should be sent back before the 19th of August 2010. After this date, no guarantee of availability or tariff can be made.
Please get in contact with the Hotel Booking Service at your earliest convenience to book your hotel or for any complementary information:
Florence THURET / Fabienne MORUCCI
Congress Department
Tel : +33 (0)4 42 16 10 09
Email : hotelcongres@aixenprovencetourism.com
Download the Hotel Registration Form
Download the Map of the Hotels
Youth Hostel
Web : www.auberge-jeunesse-aix.fr
Email : aubergejeunesseaix@wanadoo.fr
Location of the Conference and Information about Aix-en-Provence
Location of the Conference
Aix Congress Center / Centre de congrès
14, boulevard Carnot
13100 Aix-en-Provence (France)
How to go there
Download the acces map to the Congress Center
"Taxis Radio Aixois"
+33 (0)4 42 27 71 11
www.taxisradioaixois.com
From the TGV train station to the Conference Center it takes about 20 to 30 min. and the cost is around 35 euros.
This company accepts credit cards.
There are also trains arriving at the station in Aix-en-Provence so please check the name of the station.
Pratical information about acces to Aix-en-Provence
http://www.aixenprovencetourism.com/to/bienvenue.htm
For more information about Aix-en-Provence we invite you to have a look at the website of the Aix-en-Provence tourist office
A social programme will be proposed to the participants. Late afternoon on Sunday 3 a guided walk through the old centre of Aix will be organized.
The tour will start from the Congress Centre at 6:00 p.m. and its end point will be the welcome reception in the beautiful City Hall at 7:30 p.m.
The guided walk is included in the registration fee. Please confirm your participation by sending an e-mail to apgi.asso@u-psud.fr.
On Tuesday 5 evening we invite you to attend the conference dinner at the Château Pont Royal, a former coaching inn, situated in the middle of beautiful wine yards. Typical dishes from the Provence region will be served. Coaches will leave from the Congress Centre and bring you back there.
There is no extra cost for conference participants. Accompanying persons can attend the events for a total cost of 90 €.
|
Platinum Sponsor
|
|
BASF offers a broad range of active ingredients and excipients, as well as exclusive synthesis services. BASF produces APIs for a number of therapeutic applications and is the world market leader in caffeine, ibuprofen and pseudoephedrine. BASF’s excipient portfolio comprises a variety of highly functional polymers for applications such as granulation, tabletting, direct compression, coating and solubilization. The PVP-based Kollidon® grades are well-known as potent binders and disintegrants, but their unique properties allow for a much wider range of applications. With the Kollicoat® grades, BASF offers a series of coating polymers with various functions. Different types of solubilizers help to achieve optimized dissolution profiles for pharmaceutical formulations. Continuous research contributes to the permanent improvement of these products. Further information is available at: www.pharma-ingredients.basf.com Contact: Silke Werth, silke.werth@basf.com
|
|
Gold |
 |
Capsugel is the leading provider of innovative dosage forms and solutions to healthcare customers around the world. We understand the global healthcare market and can interpret customer requirements to deliver value in terms of innovative capsule delivery solutions for all types of active ingredients. With over 100 years’ experience in capsule technology and multidisciplinary expertise, we work with you from early stage development projects to marketed products. We seek to develop solid relationships with our customers based on trust, reliability and security. The flexibility of our complete range of services will match your needs at every stage of product development and marketing. Capsugel, part of Pfizer Inc, is the world's leading manufacturer and developer of capsule products, equipment and services for the pharmaceutical and associated healthcare industries. Visit www.capsugel.com or Contact us at marketing.emea@pfizer.com or by phone on +33389205725 |
|
|
Ethypharm is an international, R&D-driven Drug Delivery company, employing proprietary drug delivery technologies to help both pharmaceutical and biotechnology industries achieve their potential in the therapeutic field and prolong life cycle of their products. The company is based in Saint-Cloud and has thirty years experience in the field of Drug Delivery. It has 4 proprietary technologies in the area of oral delivery, with strong patents portfolio (Technologies and Formulations ): Oral modified release / Taste masked and oral dispersible / Bioavailability Enhancement / Abuse Deterrence Technology. With a fully integrated R&D approach, Ethypharm has the capability of manufacturing turn key products: from formulation – Pharmaceutical & clinical development – Industrial scale up - Project Management – Registration and GMP Commercial Manufacturing Worldwide. Ethypharm has developed a broad product pipeline with 50 marketed drugs and over 60 products at various stages of development. With 800 FTE worldwide, the company is strategically located in Europe, North America and Asia, under the direction of a totally integrated Quality team in control of R&D and manufacturing operations. Contact: Catherine Herry, PhD, Head of Formulation, herry.catherine@ethypharm.com |
|
 |
Merck Serono is the division for innovative prescription pharmaceuticals of Merck KGaA, Darmstadt, Germany, a global pharmaceutical and chemical company. Headquartered in Geneva, Switzerland, Merck Serono discovers, develops, manufactures and markets innovative small molecules and biopharmaceuticals to help patients with unmet medical needs. In the United States and Canada, EMD Serono operates through separately incorporated affiliates. With an annual R&D expenditure of over € 1bn, Merck Serono is committed to growing its business in specialist-focused therapeutic areas including neurodegenerative diseases, oncology, fertility and endocrinology, as well as new areas potentially arising out of research and development inautoimmune and inflammatory diseases. Contact : media.relations@merckserono.net |
|
|
Bronze
Sponsors |
 |
Croda manufactures excipients of superior quality and purity for the
global pharmaceutical market. Croda developed and utilises a
proprietary flash chromatographic process called Super Refining(tm).
This process physically removes impurities from pharmaceutical
excipients without altering their fundamental structure in any way. Our website can be found at www.croda.com/healthcare |
 |
GATTEFOSSÉ is an independent, privately owned company founded by Mr. Louis Gattefossé in 1880. Contact : Vincent Jannin, R&D Pharm Project Manager, vjannin@gattefosse.com |
|
 |
Sanofi-Aventis
is one of the world's leading pharmaceutical companies, ranking number
one in Europe. Backed by a world-class R&D organisation,
sanofi-aventis is developing leading positions in seven major
therapeutic areas: cardiovascular, thrombosis, oncology,
metabolic diseases, central nervous system,
internal medicine and vaccines. |
|
 |
SPI Pharma is a global leader in the manufacture and marketing of antacid actives, excipients and drug delivery systems for tablets, soft gelatin capsules, and fast-dissolve technologies. SPI also supplies a broad range of actives and excipients through Anzchem, our distribution business in Asia. SPI’s primary objective is to engineer functional materials that enable our customers to solve formulation problems, achieve differentiation, and gain speed to market. This is accomplished by establishing a leading position in functional materials and collaborating with our customers to deliver value added and cost effective solutions to their problems. SPI welcomes the opportunity to share our global knowledge base and experience with our customers to meet their product and formulation needs. Contact France: Marilde Courteille, EMEA Commercial Director, mcourteille@spipharma.com
|
 |
BASF will be pleased to meet you at the exhibition
|
 |
Buchi develops and produces laboratory equipment and analytical instruments for research and development laboratories, as well as for quality control, mainly in chemical, pharmaceutical and food industries worldwide. Customer demands provide the basis for our strategy and actions. We are aware that increasing customer benefits require constant innovation in all processes. Our motto : « Quality in your hands »! BUCHI group, it’s 400 employees around the world, subsidiaries in 10 countries and distributors in 60 countries. Buchi France existed since 2002 and is a subsidiarie of Buchi Labortechnick. The structure today of 18 people, is composed of a business service and marketing and an after-sales service. Buchi, it’s a team of specialist which will efficently help you in your instrument research in your equipements : the new Nanospraydryer : B-90 / the new SpeedDigester : K-439 / the new Near Infra Red spectrometer : NIRMaster. Buchi , it’s still : The Rotavapors R II, R210 et R125 / Vacuum sources: vacuum pump line V700 / the Sepacore preparative chromatography chain and also some reactors under pressure for catalyst testing, hydrogenation You have got a question ? You need a help ? You can of course contact us right now at france@buchi.com or visit our web site www.buchi.fr |
 |
Malvern Instruments is a global company that develops, manufactures and markets advanced analytical systems used in characterizing a wide variety of materials, from bulk powders to the latest nanomaterials and delicate macromolecules. Innovative technologies and powerful software produce systems that deliver industrially relevant data enabling customers to make the connection between micro (eg particle size by laser diffraction) and macro (bulk ) material properties (rheology) and chemical composition (chemical imaging with near infrared spectroscopy). Malvern laboratory, on-line and in-line solutions are proven in sectors from cement to pharmaceuticals and support the understanding, improvement and optimization of many industrial processes. Further information is available at: www.malvern.com |
 |
Pharmaceutical Development Services Ltd (PDS) provides a consultancy service for pharmaceutical product development and registration. This includes the development, manufacture and regulatory control of new and existing products and active ingredients. Our main areas of expertise are:
PDS also works with a network of consultants who can provide specialist technical knowledge when required for any pharmaceutical area. Further information is available at: www.pharmdservices.com Contact: Michael Gamlen, michael@pharmdservices.com |
 |
SOTAX
is the global leader in providing high-quality dissolution testing
systems, composite assay and content uniformity workstations and
physical tablet testing instruments for the pharmaceutical, dietary
supplement, medical device and biopharmaceutical industries. Founded in
1973 in Switzerland, SOTAX is a fast-growing group employing over 125
highly qualified and trained staff. SOTAX is represented globally by
local SOTAX agencies and distributors dealing with sales, service and
validation of instrumentation. SOTAX also offers SPS Pharma Services
(CRO), contract research lab dedicated to dissolution testing research,
method development and advanced training. In 2008, SOTAX integrated the
Zymark® automation product line, resources and services.
For more information, visit us at www.sotax.com |
 |
Based in Santa Barbara, California,
Wyatt Technology is the world's leading provider
of instruments, software, and services for absolute macromolecular characterization
to determine absolute molecular weights and
sizes of proteins, polymers, nanoparticles, etc. The DynaPro dynamic light scattering
(DLS) instruments include the single cuvette
based DynaPro NanoStar and the DynaPro Plate Reader for automated DLS measurements in
a plate format. DLS may be used for optimizing
protein solutions for crystallography, general
oligomerization characterization, or measuring
nanoparticle size.
|
 |
 |
|
 |
 |
 |
 |
CONFERENCE SERVICE.COM |  |
 |
ONDRUGDELIVERY.COM | |
